China Pharma Holdings (CPHI) Interest Coverage Ratio (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Interest Coverage Ratio came in at 70.9 in Q1 2026, down 161.95% YoY from 114.44 in Q1 2025, and up 7.1% on a QoQ basis from 76.32 in Q4 2025.
China Pharma Holdings (CPHI) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Interest Coverage Ratio data on file, last reported at 70.9 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 161.95% year-over-year to 70.9 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 45.24 (up 33.75% YoY) and the FY2025 annual result came in at 0.27, up 97.04% from the prior year.
- Interest Coverage Ratio climbed to 70.9 in Q1 2026, from 76.32 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 276.03 in Q4 2024 to a low of 76.32 in Q4 2025.
- A 5-year average of 9.16 and a median of 22.79 in 2022 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio jumped 14270.61% — and 2024, when it slumped 157419.4%.
- Tracing CPHI's Interest Coverage Ratio over 5 years: stood at 22.79 in 2022, then jumped by 120.56% to 4.69 in 2023, then soared by 5790.6% to 276.03 in 2024, then slumped by 127.65% to 76.32 in 2025, then rose by 7.1% to 70.9 in 2026.
- The last three Interest Coverage Ratio figures came in at 70.9 (Q1 2026), 76.32 (Q4 2025), and 3.03 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | China Pharma Holdings | 42.14 Mn | 41.84 Mn | 83,566.00 | -54.32 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -70.90 |
| Dec 31, 2025 | -76.32 |
| Sep 30, 2025 | -3.03 |
| Jun 30, 2025 | -32.58 |
| Mar 31, 2025 | -27.07 |
| Dec 31, 2024 | 276.03 |
| Sep 30, 2024 | -51.53 |
| Jun 30, 2024 | -69.09 |
| Mar 31, 2024 | -39.95 |
| Dec 31, 2023 | 4.69 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | -3.31 |
| Mar 31, 2023 | -5.00 |
| Dec 31, 2022 | -22.79 |
| Sep 30, 2022 | -34.33 |
| Jun 30, 2022 | 3.77 |
| Mar 31, 2022 | -4.18 |
| Dec 31, 2021 | -6.07 |
| Sep 30, 2021 | -0.03 |
| Jun 30, 2021 | -0.03 |